Abstract
The use of high energy focused ultrasound (FUS) waves to destroy tumor tissue in breast cancer is explored. High energy FUS destroys cells by raising the temperature of the treated volume high enough to denature cell proteins and bring about cellular death. The absorbed energy results in extremely high tissue gradients between target cells and surrounding tissue, so the effect of the focused energy is concentrated only at the target, leaving the healthy tissue unscathed. This phase one trial has examined the possibility of ablating breast carcinoma using MRI Guided FUS (MRIgFUS) in place of lumpectomy. Ten female patients underwent the procedure at the Chaim Sheba Medical Center between September 2002 and August 2004, using the ExAblate 2000 (InSightec, Haifa Israel Ltd.). Seven to 10 days after the procedure, all patients underwent standard lumpectomy and axillary sampling to complete standard treatment and to allow pathological evaluation of the procedure. Two patients had a complete pathological response. The remaining 8 patients had varying amounts of residual tumor; 2 had microscopic foci of residual carcinoma, 3 had 10% residual tumor, and 3 had 10-30% of residual tumor. Although still in its infancy, the future role of this type of ablation in breast cancer and other tumors is discussed.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Visiolo Ag, Rivens IH, ter Haar GR,et al: Preliminary results of a phase I dose escalation clinical trial using focused ultrasound in the treatment of localized tumors.Eur J Ultrasound 9:11–18, 1999.
Malcolm AL, ter Haar GR: Ablation of tissue volumes using high intensity focused ultrasound.Ultrasound Med Biol 22:659–669, 1996.
Hill CR, ter Haar GR, Review article: high intensity focused ultrasound-potential for cancer treatment.Br J Radiol 68:1296–1303, 1995.
Lyrun JG, zwemer RL, Chick AS, Miller AE: A new method for generation and use of focused ultrasound in experimental biology..J Gen Physiol 26:173–193, 1942.
Hynynen K, Darkazanli A, Unger E, Schenck JF: MRI-guided noninvasive ultrasound surgery.Med Phys 20:107–115,1993.
Fisher B, Anderson S, Bryant J, Margolese RG, Deutsch M, Fisher ER, Jeong JH, WolmarkN: Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer.N Engl J Med 347:1233–1241, 2002.
Gianfelice D, Khiat A, Amara M, Belblidia A, Boulanger Y: MR imaging-guided focused US ablation of breast cancer: histopathologic assessment of effectiveness- initial experience.Radiology 227:849–855, 2003. Epub 2003 Apr 24.
Gianfelice D, Khiat A, Boulanger Y, Amara M, Belblidia A: Feasibility of magnetic resonance imagingguided focused ultrasound surgery as an adjunct to tamoxifen therapy in high-risk surgical patients with breast carcinoma.J Vase Interv Radiol 14:1275–1282, 2003.
Huber PE, Jenne JW, Rastert R, Simiantonakis I, Sinn HP, Strittmatter HJ, von Fournier D, Wannenmacher MF, Debus J: A new noninvasive approach in breast cancer therapy using magnetic resonance imagingguided focused ultrasound surgery.Cancer Res 61:8441–8447, 2001.
Padhani AR: Dynamic contrast-enhanced MRI studies in human tumours.Br J Radiol 72:427–431, 1999.
Orel SG, Schnall MD: MR imaging of the breast for the detection, diagnosis, and staging of breast cancer.Radiology 220:13–30, 2001.
Kriege M, Brekelmans CT, Boetes C, Besnard PE, Zonderland HM, Obdeijn IM, Manoliu RA, Kok T, Peterse H, Tilanus-Linthorst MM, Muller SH, Meijer S, Oosterwijk JC, Beex LV, Tollenaar RA, de Koning HJ, Rutgers EJ, Klijn JG: Magnetic Resonance Imaging Screening Study Group. Efficacy of MRI and mammography for breast-cancer screening in women with a familial or genetic predisposition.N Engl J Med 351:427–437, 2004.
Warren RM, Bobrow LG, Earl HM, Britton PD, Gopalan D, Purushotham AD, Wishart GC, Benson JR, Hollingworth W: Can breast MRI help in the management of women with breast cancer treated by neoadjuvant chemotherapy?Br J Cancer 90:1349–1360, 2004.
Poortmans P, Bartelink H, Horiot JC, Struikmans H, Van den Bogaert W, Fourquet A, Jager J, Hoogenraad W, Rodrigus P, Warlam-Rodenhuis C, Collette L, Pierart M: EORTC Radiotherapy and Breast Cancer Groups. The influence of the boost technique on local control in breast conserving treatment in the EORTC ‘boost versus no boost’ randomised trial.Radiother Oncol 72:25–33, 2004.
Merrick HW 3rd, Hager E, Dobelbower RR Jr: Intraopertive radiation therapy for breast cancer.Surg Oncol Clin N Am 12:1065–1078, 2003.
Sabel MS, Skitzki J, Stoolman L, Egilmez NK, Mathiowitz E, Bailey N, Chang WJ, Chang AE: Intratumoral IL-12 and TNF-alpha-loaded microspheres lead to regression of breast cancer and systemic antitumor immunity.Ann Surg Oncol 11:147–156, 2004.
Hynynen K, Pomeroy O, Smith DN, Huber PE, McDannold NJ, Kettenbach J, Baum J, Singer S, Jolesz FA: MR imaging-guided focused ultrasound surgery of fibroadenomas in the breast: a feasibility study.Radiology 219:176–185, 2001.
Stewart EA, Gedroyc WM, Tempany CM, Quade BJ, Inbar Y, Ehrenstein T, Shushan A, Hindley JT, Goldin RD, David M, Sklair M, Rabinovici J: Focused ultrasound treatment of uterine fibroid tumors: safety and feasibility of a noninvasive thermoablative technique.Am J Obstet Gynecol 189:48–54, 2003.
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Zippel, D.B., Papa, M.Z. The use of MR imaging guided focused ultrasound in breast cancer patients; a preliminary phase one study and review. Breast Cancer 12, 32–38 (2005). https://doi.org/10.2325/jbcs.12.32
Issue Date:
DOI: https://doi.org/10.2325/jbcs.12.32